These findings have been confirmed in genetic patients in an early work involving only three individuals, pre-symptomatic gene carriers with the missense N279K MAPT gene mutation, leading to the FTD-parkinsonism linked to chromosome 17. The gene discussed is MAPT; the disease is frontotemporal dementia.